跳至主要内容
临床试验/NL-OMON39426
NL-OMON39426招募中2 期

Double umbilical cord blood transplantation in high-risk haematological patients. A phase II study focussing on the mechanism of graft predominance - HOVON 115 Double UCBT

HOVO0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age 18-70years inclusive
  • - Diagnosis of poor-risk hematological malignancy or (V)SAA relapsing after or failing immunosuppressive therapy and meeting the criteria for a MUD allo SCT
  • - Lacking a sufficiently matched volunteer unrelated donor or lacking such a donor within the required time period of <= 2 months in case of urgently needed alloSCT
  • - Availability of 2 (>=4/6) matched UCB grafts with a total nuclear cell count > 4 x 107/kg (see paragraph 8.2).
  • - WHO performance status 0-2
  • - Written informed consent

排除标准

  • - Bilirubin and/or transaminases > 2.5 x normal value
  • - Creatinine clearance < 40 ml/min
  • - Cardiac dysfunction (as defined in protocol in 8.1.2)
  • - Pulmonary function test with VC, FEV1 and/ or DCO < 50%
  • - Active, uncontrolled infection
  • - History of high dose total body irradiation
  • - Pregnant or lactating female
  • - HIV positivity;

研究者

发起方
HOVO

相似试验

进行中(未招募)
不适用
Double umbilical cord blood transplantation in high-risk hematological patients.A phase II study focussing on the mechanism of graft predominancePatients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donorMedDRA version: 14.1Level: PTClassification code 10061187Term: Haematopoietic neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-001188-55-BEHOVON Foundation70
进行中(未招募)
不适用
Double umbilical cord blood transplantation in high-risk hematological patients.A phase II study focussing on the mechanism of graft predominancePatients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donorMedDRA version: 14.1Level: PTClassification code 10061187Term: Haematopoietic neoplasmSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-001188-55-NLHOVON Foundation
招募中
不适用
Double umbilical cord blood transplantation in high-risk hematological patients.A phase II study focussing on the mechanism of graft predominance.Patients aged 18 -65 years inclusive, with high-risk hematological disease, eligible for allo MUD-SCT, lacking a matched unrelated donor and with availability of 2 (¡Ý 4/6) matched UCB units
NL-OMON22961HOVON Data Center70
进行中(未招募)
不适用
Transplantation of umbilical cord blood from unrelated donors in patients with haematological diseases using a myeloablative conditioning regimen - MAC UCBTHaematological disordersMedDRA version: 15.1Level: HLTClassification code 10018847Term: Haematological disordersSystem Organ Class: 100000004851
EUCTR2009-011818-21-GBniversity College London60
招募中
1 期
Cord blood therapy in premature babies: a safety and feasibility studycerebral palsypreterm brain injuryReproductive Health and Childbirth - Complications of newbornNeurological - Other neurological disorders
ACTRN12619001637134Monash Health20